A Novel Rat Model of Vitamin D Deficiency: Safe and Rapid Induction of Vitamin D and Calcitriol Deficiency without Hyperparathyroidism
Stavenuiter, Andrea W. D.
Arcidiacono, Maria V.
Keuning, Eelco D.
Vila Cuenca, Marc
Wee, Piet M. ter
Beelen, Robert H. J.
Vervloet, Marc G.
Dusso Rosso, Adriana
MetadataShow full item record
Vitamin D deficiency is associated with a range of clinical disorders. To study the mechanisms involved and improve treatments, animal models are tremendously useful. Current vitamin D deficient rat models have important practical limitations, including time requirements when using, exclusively, a vitamin D deficient diet. More importantly, induction of hypovitaminosis D causes significant fluctuations in parathyroid hormone (PTH) and mineral levels, complicating the interpretation of study results. To overcome these shortcomings, we report the successful induction of vitamin D deficiency within three weeks, with stable serum PTH and minerals levels, in Wistar rats. We incorporated two additional manoeuvres compared to a conventional diet. Firstly, the vitamin D depleted diet is calcium (Ca) enriched, to attenuate the development of secondary hyperparathyroidism. Secondly, six intraperitoneal injections of paricalcitol during the first two weeks are given to induce the rapid degradation of circulating vitamin D metabolites. After three weeks, serum 25-hydroxyvitamin D3 (25D) and 1,25-dihydroxyvitamin D3 (1,25D) levels had dropped below detection limits, with unchanged serum PTH, Ca, and phosphate (P) levels. Therefore, this model provides a useful tool to examine the sole effect of hypovitaminosis D, in a wide range of research settings, without confounding changes in PTH, Ca, and P.
Is part ofBioMed Research International, 2015, ID 604275
European research projects
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as cc-by (c) Stavenuiter et al., 2015
Showing items related by title, author, creator and subject.
The induction of C/EBPβ contributes to vitamin D inhibition of ADAM17 expression and parathyroid hyperplasia in kidney disease. Arcidiacono, Maria V.; Yang, Jing; Fernández i Giráldez, Elvira; Dusso Rosso, Adriana (Oxford University Press, 2015-03-01)Abstract BACKGROUND: In secondary hyperparathyroidism (SHPT), enhanced parathyroid levels of transforming growth factor-α (TGFα) increase EGF receptor (EGFR) activation causing parathyroid hyperplasia, high parathyroid ...
Differential Effects of Dabigatran and Warfarin on Bone Volume and Structure in Rats with Normal Renal Function Fusaro, Maria; Dalle Carbonare, Luca; Dusso Rosso, Adriana; Arcidiacono, Maria V.; Valenti, Maria Teresa; Aghi, Andrea; Pasho, Sabina; Gallieni, Maurizio (Public Library of Science, 2015)Background: Warfarin, a widely used anticoagulant, is a vitamin K antagonist impairing the activity of vitamin K-dependent Bone Gla Protein (BGP or Osteocalcin) and Matrix Gla Protein (MGP). Because dabigatran, a new ...
Barley-ß-glucans reduce systemic inflammation, renal injury and aortic calcification through ADAM17 and neutral-sphingomyelinase2 inhibition Arcidiacono, Maria V.; Carrillo-López, Natalia; Panizo García, Sara; Castro-Grattoni, Anabel L.; Valcheva, Petya; Ulloa, Catalina; Rodríguez-Carrio, Javier; Cardús i Figueras, Anna; Quirós-Caso, Covadonga; Martínez-Arias, Laura; Martínez-Salgado, Carlos; Motilva Casado, Mª José; Rodríguez Suárez, Carmen; Cannata-Andía, Jorge B.; Dusso Rosso, Adriana (Springer Nature, 2019-11-28)In chronic kidney disease (CKD), hyperphosphatemia-induced inflammation aggravates vascular calcification (VC) by increasing vascular smooth muscle cell (VSMC) osteogenic differentiation, ADAM17-induced renal and vascular ...